These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22097731)

  • 1. [The effect of valsartan on the expression of the receptor for advanced glycation end products in human glomerular mesangial cells].
    Zhong LN; Huang GL; Feng M; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):338-42. PubMed ID: 22097731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of advanced glycosylation end products on oxidative stress and MCP-1 in human renal mesangial cells].
    Feng M; Xu CB; Wen JP; Lin GF; Lv Q; Huang GL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Jul; 30(4):306-10, 313. PubMed ID: 25330663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan blocks advanced glycation end products-induced vcam-1 gene expression in mesangial cells by restoring Angiotensin-converting enzyme 2 level.
    Ishibashi Y; Matsui T; Yamagishi S
    Horm Metab Res; 2014 Jun; 46(6):379-83. PubMed ID: 24297485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Shen L
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
    J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
    Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
    Jiao B; Wang YS; Cheng YN; Gao JJ; Zhang QZ
    Biosci Trends; 2011 Aug; 5(4):173-81. PubMed ID: 21914953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
    Berrou J; Tostivint I; Verrecchia F; Berthier C; Boulanger E; Mauviel A; Marti HP; Wautier MP; Wautier JL; Rondeau E; Hertig A
    Int J Mol Med; 2009 Apr; 23(4):513-20. PubMed ID: 19288028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
    Ishibashi Y; Nishino Y; Matsui T; Takeuchi M; Yamagishi S
    Metabolism; 2011 Sep; 60(9):1271-7. PubMed ID: 21388644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
    Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts.
    Li DX; Deng TZ; Lv J; Ke J
    Braz J Med Biol Res; 2014 Dec; 47(12):1036-43. PubMed ID: 25387669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
    Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
    Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
    Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.